Future Science Group

In this NCTalks podcast we speak to Jeffrey Cohen, Director of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research (OH, USA). Dr Cohen has a large clinical practice and is also Director of Experimental Therapeutics program and is involved in a number of clinical trials. Today, Dr Cohen discusses the use of bone marrow transplantation as a treatment option for relapsing–remitting multiple sclerosis (MS), the subject of a Hot Topics discussion at ECTRIMS 2016 (London, UK, 14–17 September 2016). Is the technique a good option for patients? How could it be improved? What does the future of MS treatment look like? Listen to our podcast to find out Dr Cohen’s opinions on these key issues and more.